Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER3 | P43115 | 11/20 | 0.46 |
| ▸ | CTSA | P10619 | 5/20 | 0.44 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.39 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL687891 | 0.83 | PTGER3 (0.69) | PTGER3SMN1; SMN2KDM4EALDH1A1MAPK1 | |
| SCHEMBL687707 | 0.83 | PTGER3 (0.58) | PTGER3CTSASMN1; SMN2KDM4EALDH1A1 | |
| SCHEMBL688153 | 0.80 | PTGER3 (0.45) | PTGER3CTSASMN1; SMN2KDM4EALDH1A1 | |
| SCHEMBL686762 | 0.80 | PTGER3 (0.51) | PTGER3CTSASMN1; SMN2KDM4EALDH1A1 | |
| SCHEMBL686620 | 0.79 | PTGER3 (0.50) | PTGER3CTSASMN1; SMN2KDM4EALDH1A1 | |
| SCHEMBL686806 | 0.78 | PTGER3 (0.45) | PTGER3CTSA | |
| SCHEMBL688040 | 0.78 | PTGER3 (0.49) | PTGER3CTSASMN1; SMN2KDM4EALDH1A1 | |
| SCHEMBL688305 | 0.78 | PTGER3 (0.49) | PTGER3CTSASMN1; SMN2KDM4EALDH1A1 | |
| SCHEMBL688155 | 0.78 | PTGER3 (0.49) | PTGER3CTSASMN1; SMN2KDM4EALDH1A1 | |
| SCHEMBL687872 | 0.78 | PTGER3 (0.48) | PTGER3CTSASMN1; SMN2KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1203766-B1 | Carboxylic acid derivatives that inhibit the binding of integrins to their receptors | ENCYSIVE PHARMACEUTICALS INC (US) | 2012-02-29 | — | — | EP | disclosed |
| EP-1176956-B1 | CARBOXYLIC ACID DERIVATIVES THAT INHIBIT THE BINDING OF INTEGRINS TO THEIR RECEPTORS | ENCYSIVE PHARMACEUTICALS INC (US) | 2008-01-09 | — | — | EP | disclosed |
| EP-1203766-A2 | Carboxylic acid derivatives that inhibit the binding of integrins to their receptors | TEXAS BIOTECHNOLOGY CORPORATION (US) | 2002-05-08 | — | — | EP | disclosed |